Literature DB >> 22149423

Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.

Adam Castaño1, Sabahat Bokhari, Thomas H Brannagan, Julia Wynn, Mathew S Maurer.   

Abstract

We report the fourth case of transthyretin amyloidosis (ATTR) Ser23Asn in a 41-year-old Ecuadorian male. He has a pedigree that spans seven generations and involves 24 family members who suffered early cardiac death. Salient presenting symptoms were fatigue, shortness of breath, and peripheral neuropathy. The diagnosis of cardiac amyloid was confirmed by immunohistochemical staining of an endomyocardial biopsy, genotyping and by technetium pyrophosphate ((99m)Tc-PYP) scintigraphy, which remains to be established as a reliable tool to visualize myocardial amyloid involvement in patients with the Ser23Asn transthyretin (TTR) variant. The patient underwent successful combined heart and liver transplant. We add to the current ATTR literature that in patients with the rare Ser23Asn mutation, peripheral nerve in addition to cardiac involvement can occur and (99m)Tc-PYP scintigraphy can be used as an imaging modality to visualize myocardial amyloid.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22149423      PMCID: PMC4934899          DOI: 10.3109/13506129.2011.638682

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  23 in total

Review 1.  Classification of peripheral neuropathy: the long and the short of it.

Authors:  T D Sabin
Journal:  Muscle Nerve       Date:  1986-10       Impact factor: 3.217

2.  Peripheral nerve changes in amyloid neuropathy.

Authors:  P K Thomas; R H King
Journal:  Brain       Date:  1974-06       Impact factor: 13.501

3.  Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies.

Authors:  P J Dyck; E H Lambert
Journal:  Arch Neurol       Date:  1969-05

4.  A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient.

Authors:  L H Connors; R Théberge; J Skare; C E Costello; R H Falk; M Skinner
Journal:  Amyloid       Date:  1999-06       Impact factor: 7.141

5.  Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.

Authors:  Yoshiki Sekijima; Maria A Dendle; Jeffery W Kelly
Journal:  Amyloid       Date:  2006-12       Impact factor: 7.141

6.  Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation.

Authors:  P R Bergethon; T D Sabin; D Lewis; R W Simms; A S Cohen; M Skinner
Journal:  Neurology       Date:  1996-10       Impact factor: 9.910

Review 7.  Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy.

Authors:  J T Willerson; R W Parkey; F J Bonte; S E Lewis; J Corbett; L M Buja
Journal:  Semin Nucl Med       Date:  1980-01       Impact factor: 4.446

8.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Authors:  Helen J Lachmann; David R Booth; Susanne E Booth; Alison Bybee; Janet A Gilbertson; Julian D Gillmore; Mark B Pepys; Philip N Hawkins
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  Peripheral nerve fibre changes in asymptomatic children of patients with familial amyloid polyneuropathy.

Authors:  J Carvalho; A Coimbra; C Andrade
Journal:  Brain       Date:  1976-03       Impact factor: 13.501

10.  Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the noninvasive diagnosis of cardiac amyloidosis.

Authors:  T A Wizenberg; J Muz; Y H Sohn; W Samlowski; A M Weissler
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

View more
  6 in total

Review 1.  Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology.

Authors:  Mathew S Maurer
Journal:  Am J Med       Date:  2015-06-17       Impact factor: 4.965

2.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

Review 3.  Other types of diffuse liver disease: is there a way to do it?

Authors:  Hilton Leao Filho; Camila Vilela de Oliveira; Natally Horvat
Journal:  Abdom Radiol (NY)       Date:  2020-11

4.  Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging.

Authors:  Akhil Shukla; David Wong; Julie A Humphries; Benjamin T Fitzgerald; Katrina Newbigin; John Bashford; Gregory M Scalia
Journal:  CASE (Phila)       Date:  2017-04-24

Review 5.  Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.

Authors:  Weijia Li; Dipan Uppal; Yu-Chiang Wang; Xiaobo Xu; Damianos G Kokkinidis; Mark I Travin; James M Tauras
Journal:  Diagnostics (Basel)       Date:  2021-05-30

Review 6.  Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.

Authors:  Maria Papathanasiou; Alexander Carpinteiro; David Kersting; Aiste-Monika Jakstaite; Tim Hagenacker; Thomas-Wilfried Schlosser; Christoph Rischpler; Tienush Rassaf; Peter Luedike
Journal:  Mol Genet Genomic Med       Date:  2020-12-20       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.